Crossref journal-article
American Society for Microbiology
Journal of Virology (235)
Abstract

ABSTRACTSkin keratinocytes provide a first line of defense against invading microorganisms in two ways: (i) by acting as a physical barrier to pathogen entry and (ii) by initiating a vigorous innate immune response upon sensing danger signals. How keratinocytes detect virus infections and generate antiviral immune responses is not well understood. Orthopoxviruses are dermatotropic DNA viruses that cause lethal disease in humans. Virulence in animal models depends on the virus-encoded bifunctional Z-DNA/double-stranded RNA (dsRNA)-binding protein E3. Here, we report that infection of mouse primary keratinocytes with a vaccinia ΔE3L mutant virus triggers the production of beta interferon (IFN-β), interleukin-6 (IL-6), CCL4, and CCL5. None of these immune mediators is produced by keratinocytes infected with wild-type vaccinia virus. The dsRNA-binding domain of E3 suffices to prevent activation of the innate immune response. ΔE3L induction of IFN-β, IL-6, CCL4, and CCL5 secretion requires mitochondrial antiviral signaling protein (MAVS; an adaptor for the cytoplasmic viral RNA sensors RIG-I and MDA5) and the transcription factor IRF3. IRF3 phosphorylation is induced in keratinocytes infected with ΔE3L, an event that depends on MAVS. The response of keratinocytes to ΔE3L is unaffected by genetic ablation of Toll-like receptor 3 (TLR3), TRIF, TLR9, and MyD88.

Bibliography

Deng, L., Dai, P., Parikh, T., Cao, H., Bhoj, V., Sun, Q., Chen, Z., Merghoub, T., Houghton, A., & Shuman, S. (2008). Vaccinia Virus Subverts a Mitochondrial Antiviral Signaling Protein-Dependent Innate Immune Response in Keratinocytes through Its Double-Stranded RNA Binding Protein, E3. Journal of Virology, 82(21), 10735–10746.

Authors 10
  1. Liang Deng (first)
  2. Peihong Dai (additional)
  3. Tanvi Parikh (additional)
  4. Hua Cao (additional)
  5. Vijay Bhoj (additional)
  6. Qinmiao Sun (additional)
  7. Zhijian Chen (additional)
  8. Taha Merghoub (additional)
  9. Alan Houghton (additional)
  10. Stewart Shuman (additional)
References 75 Referenced 51
  1. 10.1016/j.cell.2006.02.015
  2. Alcamí, A., J. A. Symons, P. D. Collins, T. J. Williams, and G. L. Smith. 1998. Blockade of chemokine activity by a soluble chemokine blocking protein from vaccinia virus. J. Immunol.160:624-633. (10.4049/jimmunol.160.2.624) / J. Immunol. (1998)
  3. 10.1038/35099560
  4. 10.1128/JVI.00576-06
  5. 10.1007/BF00370005
  6. Braff, M. H., and R. L. Gallo. 2006. Antimicrobial peptides: an essential component of the skin defensive barrier. Curr. Top. Microbiol. Immunol.306:91-110. / Curr. Top. Microbiol. Immunol. (2006)
  7. 10.1016/j.virol.2005.01.006
  8. 10.1128/JVI.75.2.850-856.2001
  9. 10.1006/viro.1993.1292
  10. 10.1073/pnas.89.11.4825
  11. 10.1128/jvi.69.10.6605-6608.1995
  12. 10.1016/j.molcel.2007.10.032
  13. 10.1038/sj.jid.5700294
  14. 10.1128/JVI.00354-06
  15. 10.1016/S1074-7613(02)00390-4
  16. 10.1128/MMBR.00027-06
  17. 10.1074/jbc.M706777200
  18. 10.4049/jimmunol.164.10.5352
  19. 10.1073/pnas.0405586101
  20. 10.1128/jvi.70.4.2611-2614.1996
  21. 10.1006/viro.1996.0114
  22. 10.1073/pnas.0403555101
  23. 10.1128/JVI.77.15.8394-8407.2003
  24. 10.1126/science.1132505
  25. 10.4049/jimmunol.172.3.1763
  26. 10.1016/j.immuni.2006.02.006
  27. 10.1073/pnas.92.24.11284
  28. 10.1038/nature04734
  29. 10.1016/j.immuni.2005.04.010
  30. 10.1016/S0923-1811(02)00105-6
  31. 10.1038/ni1303
  32. 10.1038/ni1243
  33. 10.1073/pnas.0308260100
  34. 10.1073/pnas.0431131100
  35. 10.1038/368339a0
  36. 10.1182/blood-2003-08-2674
  37. 10.1006/viro.2002.1479
  38. 10.1128/JVI.00607-06
  39. 10.1038/sj.jid.5700530
  40. 10.1046/j.1523-1747.2003.12245.x
  41. 10.1128/JVI.78.4.1675-1684.2004
  42. 10.1126/science.1155406
  43. 10.1128/JVI.79.12.7363-7370.2005
  44. 10.1128/JVI.79.4.2584-2596.2005
  45. 10.1099/vir.0.81623-0
  46. 10.1084/jem.20030162
  47. 10.1111/j.1523-1747.2003.12630.x
  48. 10.1038/nature04193
  49. 10.4049/jimmunol.174.10.6137
  50. 10.1126/science.8009221
  51. 10.1016/j.virol.2006.03.004
  52. 10.1126/science.1147347
  53. 10.1074/jbc.M305820200
  54. 10.4049/jimmunol.170.3.1435
  55. 10.1128/MCB.18.12.7304
  56. 10.1016/S1074-7613(00)00053-4
  57. 10.1146/annurev.immunol.21.120601.141049
  58. 10.1016/j.cell.2005.08.012
  59. 10.1126/science.1081315
  60. 10.1074/jbc.M008717200
  61. 10.1128/JVI.01300-07
  62. 10.1016/j.immuni.2006.04.004
  63. 10.1073/pnas.0400525101
  64. 10.1016/j.molcel.2007.11.028
  65. 10.1111/j.1462-5822.2006.00716.x
  66. 10.1016/j.bbrc.2005.07.105
  67. 10.1016/j.vaccine.2007.11.045
  68. 10.1086/587668
  69. 10.1097/01.all.0000136758.66442.28
  70. 10.1128/JVI.76.10.5251-5259.2002
  71. 10.1016/j.molcel.2005.08.014
  72. 10.1126/science.1087262
  73. 10.1038/ni1087
  74. 10.1073/pnas.0602142103
  75. 10.1128/JVI.01891-07
Dates
Type When
Created 17 years ago (Aug. 20, 2008, 8:15 p.m.)
Deposited 2 years, 3 months ago (May 19, 2023, 1:42 p.m.)
Indexed 1 month, 1 week ago (July 14, 2025, 11:18 p.m.)
Issued 16 years, 9 months ago (Nov. 1, 2008)
Published 16 years, 9 months ago (Nov. 1, 2008)
Published Print 16 years, 9 months ago (Nov. 1, 2008)
Funders 0

None

@article{Deng_2008, title={Vaccinia Virus Subverts a Mitochondrial Antiviral Signaling Protein-Dependent Innate Immune Response in Keratinocytes through Its Double-Stranded RNA Binding Protein, E3}, volume={82}, ISSN={1098-5514}, url={http://dx.doi.org/10.1128/jvi.01305-08}, DOI={10.1128/jvi.01305-08}, number={21}, journal={Journal of Virology}, publisher={American Society for Microbiology}, author={Deng, Liang and Dai, Peihong and Parikh, Tanvi and Cao, Hua and Bhoj, Vijay and Sun, Qinmiao and Chen, Zhijian and Merghoub, Taha and Houghton, Alan and Shuman, Stewart}, year={2008}, month=nov, pages={10735–10746} }